Cross-Protective Abilities of Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Mucosal Adjuvant against Infection with Heterologous Influenza Viruses.

Abstract

Mucosal vaccination, which secretion of immunoglobulin A (IgA) on the mucosa is accompanied by induction of immunoglobulin G (IgG) in the blood, is one of the most effective ways to circumvent influenza epidemics caused by incorrect prediction of epidemic viral strains or viral mutation. Secreted IgA is expected to prevent hosts from being infected with heterologous viruses because this antibody cross-reacts to strains other than those used for immunization. Our previous mouse experiments revealed that intranasal IgA with cross-reactivity was induced through nasal inoculation with inactivated whole viral particles of the H1N1 A/New Caledonia/20/99 IVR116 (NCL) strain in the presence of hyaluronic acid modified with tetraglycine-l-octaarginine. In the present study, heterologous influenza virus challenge was performed to validate a potential of the hyaluronic acid derivative as a mucosal adjuvant with cross-protective abilities. Serious weight loss was observed when mice were nasally inoculated with inactivated NCL viruses alone and subsequently exposed to mouse-adapted infectious viruses of the H1N1 A/Puerto Rico/8/34 (PR8) strain. The symptom associated with virus infection was hardly ever observed for mice inoculated with a mixture of the viral antigens and tetraglycine-l-octaarginine-linked hyaluronic acid, presumably due to high induction of IgG and IgA capable of cross-reacting to PR8 viruses. Less proliferation of PR8 viruses in those mice was also supported by an insignificant elevation of antibody levels through virus exposure. Our polysaccharide derivative enabled hosts to acquire adaptive immunity with cross-protective abilities against heterologous virus infection.

• Authors: Sohei Tanishita, Masami Ukawa, Takumi Tomono, Yuki Yoshida, Takumi Tsujioka, Kohei Miyata, Etsuo Tobita, Tomofumi Uto, Masanori Baba, Shinji Sakuma
• Journal: Bioconjugate chemistry (Bioconjug Chem) Vol. 30 Issue 12 Pg. 3028-3037 (12 18 2019) ISSN: 1520-4812 [Electronic] United States
• PMID: 31738536 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Adjuvants, Immunologic
• Immunoglobulin A
• Immunoglobulin G
• Influenza Vaccines
• Oligopeptides
• octaarginine
• Hyaluronic Acid
• glycyl-glycyl-glycyl-glycine

Topics

• Adjuvants, Immunologic (chemistry, pharmacology)
• Administration, Intranasal
• Animals
• Cross Reactions (immunology)
• Humans
• Hyaluronic Acid (chemistry, pharmacology)
• Immunoglobulin A (metabolism)
• Immunoglobulin G (metabolism)
• Influenza A Virus, H1N1 Subtype (immunology)
• Influenza Vaccines (chemistry)
• Influenza, Human (prevention & control)
• Influenzavirus A (immunology)
• Mice
• Oligopeptides (chemistry)